En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
INNOSUISSE
Numéro de projet
9125.1;7 PFNM-NM
Titre du projet
Microfluidic platform for fast immunoassays
Titre du projet anglais
Microfluidic platform for fast immunoassays

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Description succincte
-
Anzeigen
-
Anzeigen
Résumé des résultats (Abstract)
-
Anzeigen
-
Anzeigen

Textes saisis


CatégorieTexte
Description succincte
(Anglais)
Microfluidic platform for fast immunoassays
Description succincte
(Français)
Microfluidic platform for fast immunoassays
Résumé des résultats (Abstract)
(Anglais)
The aim of this project is to develop a novel microfluidic platform for fast immunoassays using the immunochip developed by DiagnoSwiss, but with a enhanced loading capacity and an interface to mass spectrometry analysis. The first generation of instruments with electrochemical detection has demonstrated that it was possible to use microfluidics to reduce the size of an ELISA assay down to nanoliters range, thereby decreasing dramatically the analysis time. This first generation of ELISA assay instrument is now commercially available in a robotic version under the trade name GRAVITM-Chip.The first goal of this project is to combine magnetic beads technology to the microfluidic immunochip in order to increase the sorbing capacity of antigens so as to lower the detection limit. The second goal is to interface the immunochip directly to mass spectrometry to obtain a direct detection without the use of an enzymatic amplification step. The new instrument will benefit from an automated sample dispensing unit, from novel stationary phases and a well-proven electrospray ionisation unit.
Résumé des résultats (Abstract)
(Français)
The aim of this project is to develop a novel microfluidic platform for fast immunoassays using the immunochip developed by DiagnoSwiss, but with a enhanced loading capacity and an interface to mass spectrometry analysis. The first generation of instruments with electrochemical detection has demonstrated that it was possible to use microfluidics to reduce the size of an ELISA assay down to nanoliters range, thereby decreasing dramatically the analysis time. This first generation of ELISA assay instrument is now commercially available in a robotic version under the trade name GRAVITM-Chip.The first goal of this project is to combine magnetic beads technology to the microfluidic immunochip in order to increase the sorbing capacity of antigens so as to lower the detection limit. The second goal is to interface the immunochip directly to mass spectrometry to obtain a direct detection without the use of an enzymatic amplification step. The new instrument will benefit from an automated sample dispensing unit, from novel stationary phases and a well-proven electrospray ionisation unit.